期刊文献+

克林霉素联合伯氨喹啉补救治疗肺孢子菌肺炎一例 被引量:2

原文传递
导出
摘要 肺孢子菌肺炎(PCP)是艾滋病患者最常见的机会性感染。近年来随着免疫功能抑制患者的增多,非艾滋病的PCP病例明显增加,且更难诊断,预后更差。PCP一线治疗失败后及时行“补救治疗”对改善患者预后至关重要。现报道1例抑郁症合并PCP的病例,磺胺及卡泊芬净治疗失败后采用克林霉素联合伯氨喹啉补救治疗获得成功的病例。
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2009年第9期714-715,共2页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献8

  • 1Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med, 2004, 350:2487-2498.
  • 2Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodefieiency syndrome: associated illness and prior eorticosteroid therapy. Mayo Clin Proc, 1996, 71:5-13.
  • 3Smego RA Jr, Nagar S, Maloba B, et al. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med, 2001, 161:1529-1533.
  • 4Masur H, Kaplan JE, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infeeted persons- 2002 : recommendations of the U. S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med, 2002, 137:435-478.
  • 5Li J, Huang XM, Fang WG, et al. Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol, 2006, 12 : 114-117.
  • 6Anesi A, Franciotta D, Di Paolo E, et al. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders. Funct Neurol, 1994, 9 : 17-22.
  • 7Navin TR, Beard CB, Huang L, et al. Effect of mutations in Pneumocystis carinii dihydroptemate synthase gene on outcome of P cariuii pneumonia in patients with HIV-1: a prospective study. Lancet, 2001, 358:545-549.
  • 8张进川,戴建业,樊谨,吴雪萍.卡泊芬净治疗老年卡氏肺孢子菌肺炎一例并文献复习[J].中华结核和呼吸杂志,2006,29(7):463-465. 被引量:34

二级参考文献10

  • 1陈辉,刘维达.新型抗真菌药物卡泊芬净及其在临床的应用[J].国外医学(皮肤性病学分册),2005,31(1):9-11. 被引量:18
  • 2张进川.长期住院机械通气老年患者卡氏肺囊虫肺炎的诊治[J].中华老年医学杂志,2005,24(1):15-17. 被引量:14
  • 3Morris A,Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS,2003,17:73-80.
  • 4Fisk DT, Meshnick S,Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis,2003,36:70-78.
  • 5Annaloro C, Della Volpe A, Usardi P, et al. Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation. Eur J Clin Microbiol Infect Dis,2006,25:52-54.
  • 6Edman U, Edman JC, Lundgren B, et al. Isolation and expression of the Pneumocystis carinii thymidylate synthase gene. Proc Natl Acad Sci U S A, 1989,86:6503-6507.
  • 7Santamauro JT, Stover DE. Pneumocystis carinii pneumonia. Med Clin North Am,1997,81:299-318.
  • 8Powles MA, Liberator P, Anderson J, et al. Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii. Antimicrob Agents Chemother,1998,42:1985-1989.
  • 9Ma L,Kovacs JA,Cargnel A,et al. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis, 2002,185 : 1530-1532.
  • 10Helweg-Larsen J, Benfield TL, Eugen-Olsen J, et al. Effects of mutations in Pneumocystis carinii dihydmptemate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet, 1999,354 : 1347-1351.

共引文献33

同被引文献3

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部